Welcome, Guest. Please login or register.
March 19, 2024, 07:20:14 am

Login with username, password and session length


Members
Stats
  • Total Posts: 772787
  • Total Topics: 66296
  • Online Today: 290
  • Online Ever: 5484
  • (June 18, 2021, 11:15:29 pm)
Users Online
Users: 2
Guests: 231
Total: 233

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Shock and kill research update  (Read 3271 times)

0 Members and 1 Guest are viewing this topic.

Offline Almost2late

  • Member
  • Posts: 1,447
Shock and kill research update
« on: July 18, 2017, 12:48:42 am »
Seems that Vorinostat not only helps reduce latent hiv reservoirs but it's also fairly safe.. really wouldn't mind getting some of my own reservoirs reduced a bit.. while not a cure for now, it might help with inflammation and/or frequent blips..

https://m.medicalxpress.com/news/2017-07-advances-ability-expose-latent-hiv.html

Quote
Study advances the ability to expose latent HIV

Exposing hidden HIV reservoirs so that they can be cleared is a strategy being tested in efforts to develop therapies to cure the nearly 40 million people worldwide living with HIV. Researchers at the University of North Carolina at Chapel Hill have shown that interval dosing of the drug Vorinostat reverses HIV latency and is well-tolerated in people living with HIV. However, while Vorinostat makes latent HIV easier to detect, it does not clear or deplete infection, meaning additional advances will be needed to achieve a cure. These results were published in the Journal of Clinical Investigation on July 17.

The team studied Vorinostat in 16 patients living with HIV whose viral load was controlled through standard antiviral therapy. Doses of Vorinostat were administered at 48 or 72-hour intervals. The team found that HIV could be more easily detected within latently infected CD4+ T cells when Vorinostat was administered once every three days, even though control of viral load in the blood was maintained.

"We showed that a single dose of Vorinostat could expose the hidden virus several years ago, but it has taken two studies over the last five years to define the proper interval dosing strategy to use Vorinostat safely and effectively," said Nancie Archin Ph.D., lead author of this study and an assistant professor in the Division of Infectious Diseases at UNC. "Now we can attempt to chip away the viral reservoir."

Over a month of treatment with Vorinostat few side effects and no serious toxicities were seen, but depletion of latent infection was not found. The team believes pairing a latency reversing agent, like Vorinostat, with an antiviral immune therapy, such as a vaccine or an antibody capable of recognizing and clearing the latent cells, will be needed to achieve a cure.

"We have now been able to begin two small, intensive studies pairing Vorinostat with an anti-HIV vaccine produced by Argos Therapeutics, or with an infusion of antiviral immune cells prepared by Cath Bollard's laboratory at Children's National Medical Center, in an attempt to test combined approaches to clearing HIV infection," said David Margolis, M.D., director of the UNC HIV Cure Center at the UNC Institute for Global Health & Infectious Diseases. "We do not expect immediate success, but hope to make progress towards the goal of developing treatments that someday might clear HIV infection."

Offline gorka

  • Member
  • Posts: 103
Re: Shock and kill research update
« Reply #1 on: July 18, 2017, 07:06:01 pm »
I thought British team is ahead of them and are already using another drug and vaccine.  Results are expected sometime in 2018

Offline Almost2late

  • Member
  • Posts: 1,447
Re: Shock and kill research update
« Reply #2 on: July 18, 2017, 10:17:22 pm »
I thought British team is ahead of them and are already using another drug and vaccine.  Results are expected sometime in 2018

Awesome

Offline Mightysure

  • Member
  • Posts: 449
Re: Shock and kill research update
« Reply #3 on: July 22, 2017, 03:49:07 pm »
Yea. I would have loved to have tried it, but apparently you can't have a low reservoir for the research study.
« Last Edit: July 22, 2017, 04:11:33 pm by Mightysure »

 


Terms of Membership for these forums
 

© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.